FDA supplement claims explained: what brands can and cannot imply

This page is for readers who see supplement claims such as supports immunity, promotes heart health, balances hormones, detoxifies, fights inflammation, or works like a drug and want to know which claims deserve extra caution.

It is also a public explanation of why HAA avoids disease-treatment wording even when a topic has real scientific interest.

FDA describes several types of claims used on foods and dietary supplements, including health claims, nutrient content claims, and structure/function claims.

A health claim links a substance to reduced risk of a disease or health-related condition and has a higher regulatory bar. A nutrient content claim characterizes the level of a nutrient. A structure/function claim describes how a nutrient or dietary ingredient affects normal structure or function of the body.

A structure/function claim can use language like supports bone health or helps maintain normal immune function when requirements are met. It should not say or imply that the supplement treats osteoporosis, cures infections, reverses diabetes, prevents heart attacks, or replaces a prescription drug.

When HAA rewrites claims into support language, it is preserving this boundary.

If a dietary supplement label uses a structure/function claim, related nutrient-deficiency claim, or general well-being claim, FDA materials explain that the label must carry a disclaimer that FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure, or prevent disease.

That disclaimer does not mean the claim is automatically false. It means the claim has not gone through the drug-approval pathway and should not be read like an approved medical indication.

FDA label categories do not give marketers permission to exaggerate. FTC health-product guidance focuses on whether advertising claims are truthful, not misleading, and supported by competent and reliable evidence.

For HAA, this means a page should not repeat a brand's strongest claim unless the evidence actually supports that level of certainty.

HAA treats the following as red flags: FDA-approved language for a dietary supplement, disease-treatment wording, drug-comparison promises, guaranteed results, before-and-after cure framing, detox claims without a defined mechanism, and supplement protocols for prescription-drug users without clinician-first caveats.

The stronger the medical implication, the stronger the evidence and review standard must be.

HAA can explain evidence, rank products, discuss mechanisms, and flag promising research. It should not tell readers that a supplement treats, cures, prevents, or replaces medical care.

This is not only regulatory caution. It is how a healthy-aging site earns long-term trust in a YMYL category.